Birdwatch Note
2023-04-23 22:34:36 UTC - NOT_MISLEADING
The sources listed in the note refer to study about dose differences. They do not show that the drug has not harmed Covid 19 patients. The link of this drug to kidney failure is well established https://pubmed.ncbi.nlm.nih.gov/33340409/ https://www.frontiersin.org/articles/10.3389/fphar.2022.692828/full It also has high probability of cardiotoxic effect https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511861/ https://m.timesofindia.com/life-style/health-fitness/health-news/covid-drug-remdesivir-has-potential-to-cause-serious-adverse-effects-to-heart-study/articleshow/98936779.cms No note needed.
Written by 93BC76D0B2B42D81AC185DFBE58C20769F1E24BF3ADACD7718B27E11DF6437F7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1650132608758472704
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1650266953762893824
- noteId - 1650266953762893824
- participantId -
- noteAuthorParticipantId - 93BC76D0B2B42D81AC185DFBE58C20769F1E24BF3ADACD7718B27E11DF6437F7 Participant Details
- createdAtMillis - 1682289276913
- tweetId - 1650132608758472704
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 1
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 1
- trustworthySources - 1
- summary
- The sources listed in the note refer to study about dose differences. They do not show that the drug has not harmed Covid 19 patients. The link of this drug to kidney failure is well established https://pubmed.ncbi.nlm.nih.gov/33340409/ https://www.frontiersin.org/articles/10.3389/fphar.2022.692828/full It also has high probability of cardiotoxic effect https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511861/ https://m.timesofindia.com/life-style/health-fitness/health-news/covid-drug-remdesivir-has-potential-to-cause-serious-adverse-effects-to-heart-study/articleshow/98936779.cms No note needed.
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-04-23 22:34:36 UTC (1682289276913) |
1969-12-31 23:59:59 UTC (-1) |
2023-05-06 02:42:24 UTC (1683340944665) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-05-01 17:28:36 -0500 | Rating Details | |
2023-04-29 19:05:54 -0500 | Rating Details | |
2023-05-13 02:03:06 -0500 | Rating Details | |
2023-04-23 21:18:18 -0500 | Rating Details | |
2023-04-23 20:35:21 -0500 | Rating Details | |
2023-04-23 17:49:07 -0500 | Rating Details | |
2023-04-23 20:36:09 -0500 | Rating Details | |
2023-04-23 20:02:46 -0500 | Rating Details | |
2023-04-23 20:05:57 -0500 | Rating Details | |
2023-04-23 20:24:06 -0500 | Rating Details | |
2023-04-23 21:24:49 -0500 | Rating Details | |
2023-04-23 19:50:47 -0500 | Rating Details | |
2023-04-23 22:03:53 -0500 | Rating Details | |
2023-04-25 09:59:57 -0500 | Rating Details | |
2023-04-23 22:18:22 -0500 | Rating Details | |
2023-04-23 19:56:51 -0500 | Rating Details | |
2023-04-23 20:24:17 -0500 | Rating Details | |
2023-04-23 23:50:57 -0500 | Rating Details | |
2023-04-23 23:13:35 -0500 | Rating Details | |
2023-04-23 20:43:08 -0500 | Rating Details | |
2023-04-23 21:24:59 -0500 | Rating Details | |
2023-04-23 21:28:28 -0500 | Rating Details | |
2023-04-23 19:44:07 -0500 | Rating Details | |
2023-04-23 20:06:19 -0500 | Rating Details | |
2023-04-23 20:54:11 -0500 | Rating Details | |
2023-04-23 21:06:39 -0500 | Rating Details | |
2023-04-23 22:37:39 -0500 | Rating Details | |
2023-04-23 21:16:16 -0500 | Rating Details | |
2023-04-23 19:51:23 -0500 | Rating Details | |
2023-04-23 21:44:53 -0500 | Rating Details | |
2023-04-23 18:29:09 -0500 | Rating Details | |
2023-04-23 20:15:04 -0500 | Rating Details | |
2023-04-23 20:41:13 -0500 | Rating Details | |
2023-04-23 19:59:12 -0500 | Rating Details | |
2023-04-23 21:18:18 -0500 | Rating Details | |
2023-04-23 20:35:21 -0500 | Rating Details | |
2023-04-23 17:49:07 -0500 | Rating Details | |
2023-04-23 20:36:09 -0500 | Rating Details | |
2023-04-23 20:02:46 -0500 | Rating Details | |
2023-04-23 20:05:57 -0500 | Rating Details | |
2023-04-23 20:24:06 -0500 | Rating Details | |
2023-05-13 02:03:06 -0500 | Rating Details | |
2023-04-23 21:24:49 -0500 | Rating Details | |
2023-04-23 19:50:47 -0500 | Rating Details | |
2023-04-23 22:03:53 -0500 | Rating Details | |
2023-04-25 09:59:57 -0500 | Rating Details | |
2023-04-23 22:18:22 -0500 | Rating Details | |
2023-04-23 19:56:51 -0500 | Rating Details | |
2023-04-23 20:24:17 -0500 | Rating Details | |
2023-04-23 23:50:57 -0500 | Rating Details | |
2023-04-23 23:13:35 -0500 | Rating Details | |
2023-04-23 20:43:08 -0500 | Rating Details | |
2023-04-23 21:24:59 -0500 | Rating Details | |
2023-05-01 17:28:36 -0500 | Rating Details | |
2023-04-23 21:28:28 -0500 | Rating Details | |
2023-04-23 19:44:07 -0500 | Rating Details | |
2023-04-23 20:06:19 -0500 | Rating Details | |
2023-04-23 20:54:11 -0500 | Rating Details | |
2023-04-23 21:06:39 -0500 | Rating Details | |
2023-04-23 22:37:39 -0500 | Rating Details | |
2023-04-23 21:16:16 -0500 | Rating Details | |
2023-04-23 19:51:23 -0500 | Rating Details | |
2023-04-23 21:44:53 -0500 | Rating Details | |
2023-04-23 18:29:09 -0500 | Rating Details | |
2023-04-29 19:05:54 -0500 | Rating Details | |
2023-04-23 20:15:04 -0500 | Rating Details | |
2023-04-23 20:41:13 -0500 | Rating Details | |
2023-04-23 19:59:12 -0500 | Rating Details | |
2023-07-28 06:49:52 -0500 | Rating Details |